Maria Beatrice Panico

Dr Maria Beatrice Panico is a medical doctor, fully qualified neurologist and has a PhD in neuroscience. She is the Chief Medical Officer at Scendea, responsible for providing clinical and regulatory advice across a wide range of development programs of medicinal products (UK, EU and US jurisdictions). Beatrice was formerly a Leading Senior Medical Assessor at the UK Regulatory Authority, the MHRA, and represented the UK in the European working groups on new trial designs, safety and In Vitro Diagnostic Medical Devices. She is one of the authors of the CTFG Recommendation Paper on the Initiation and Conduct of Complex Clinical Trials. She was the UK contact person for safety in clinical trials and is the author of the MHRA/Health Canada Development Safety Update Report (DSUR) guidance. She worked on the Ebola epidemic and Covid19 pandemic. Before joining the MHRA she worked as a clinical neurologist, clinical investigator, researcher in neuroscience and pharmacovigilance expert in the